Abstract
The detection of nucleated red blood cells (NRBCs) in blood of patients suffering from a variety of severe diseases is known to be highly associated with increased mortality. Blood analyzers to routinely measure NRBC concentrations are now available. However, the diagnostic and prognostic significance of this parameter for intensive care patients has not been evaluated. Using a Sysmex XE-2100 analyzer, NRBC concentrations were determined in blood samples from 421 patients treated in intensive care units (general and accident surgery, cardiothoracic surgery, and internal medicine) of a university hospital. NRBCs were found at least once in 19.2% of all patients. The mortality of NRBC-positive patients (n = 81) was 42.0% (n = 34); this was significantly higher (p < 0.001) than the mortality of NRBC-negative patients (5.9%, n = 340). The NRBC concentration was 115 ± 4 × 106/l (median 40 × 106/l; range 20–2930 × 106/l) at initial detection of NRBCs in the blood. Mortality increased with increasing NRBC concentration and increasing frequency of occurrence. With regard to in-hospital mortality, NRBCs in blood showed sensitivity and specificity of 63.0% and 87.2%, respectively. The detection of NRBCs is highly predictive of death, the odds ratio after adjustment for other laboratory prognostic indicators being 1.01 (p < 0.01) for each increase in the NRBC concentration of +1 × 106/l. NRBCs were detected for the first time, on average, 13 days (median 8 days) before death. The routine analysis of NRBCs in blood is of high prognostic power with regard to in-hospital mortality of critically ill patients. Therefore, this parameter may serve as an early indicator for patients at increased mortality risk.
References
1 Schwartz SO. Significance of nucleated red blood cells in peripheral blood. J Am Med Assoc 1954; 154:1339–40.10.1001/jama.1954.02940500019007Search in Google Scholar
2 Delsol G, Guiu-Godfrin B, Guiu M, Pris J, Corberand J, Fabre J. Leukoerythroblastosis and cancer frequency, prognosis, and physiopathologic significance. Cancer 1979; 44:1009–13.10.1002/1097-0142(197909)44:3<1009::AID-CNCR2820440331>3.0.CO;2-JSearch in Google Scholar
3 Budmiger H, Graf C, Streuli RA. The leukoerythroblastic blood picture. Incidence and clinical significance. Schweiz Rundsch Med Prax 1984; 73:1489–93.Search in Google Scholar
4 Weick JK, Hagedorn AB, Linman JW. Leukoerythroblastosis. Mayo Clin Proc 1974; 49:110–3.Search in Google Scholar
5 West CD, Ley AB, Pearson OH. Myelophthisic anemia in cancer of the breast. Am J Med 1955; 18:923–31.10.1016/0002-9343(55)90173-XSearch in Google Scholar
6 Mettier SR. Hematologic aspects of space consuming lesions of the bone marrow (myelophtisic anemia). Ann Intern Med 1940; 14:436–48.10.7326/0003-4819-14-3-436Search in Google Scholar
7 Andres WA. Normoblastemia after thermal injury. Am J Surg 1976; 131:725–6.10.1016/0002-9610(76)90188-4Search in Google Scholar
8 Tavassoli M. Erythroblastemia. West J Med 1975; 122:194–8.Search in Google Scholar
9 Stachon A, BöningA, Krismann M, Weisser H, Laczkovics A, Skipka G, et al. Prognostic significance of erythroblasts in blood after cardiothoracic surgery. Clin Chem Lab Med 2001; 39:239–43.10.1515/CCLM.2001.038Search in Google Scholar
10 Ruzicka K, Veitl M, Thalhammer-Scherrer R, Schwarzinger I. The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology. Arch Pathol Lab Med 2001; 125:391–6.10.5858/2001-125-0391-TNHASXSearch in Google Scholar
11 Walters J, Garrity P. Performance evaluation of the Sysmex XE-2100 hematology analyser. Lab Hematol 2000; 6:83–92.Search in Google Scholar
12 Briggs C, Harrison P, Grant D, Staves J, Maciag T. New quantitative parameters on recently introduced automated blood cell counter – the XE 2100™. Clin Lab Haematol 2000; 22:345–50.10.1046/j.1365-2257.2000.00330.xSearch in Google Scholar
13 Stachon A, Sondermann N, Krieg M. Incidence of nucleated red blood cells in the blood of hospitalised patients. Infusion Ther Transfus Med 2001; 28:263–6.10.1159/000050251Search in Google Scholar
14 Stachon A, Sondermann N, Imöhl M, Krieg M. Nucleated red blood cells indicate high risk for in-hospital mortality. J Lab Clin Med 2002; 140:407–12.10.1067/mlc.2002.129337Search in Google Scholar
15 Böning A, Stachon A, Weisser H, Krismann M, Skipka G, Laczkovics A, et al. Postoperative cholesterol and erythroblasts as a parameter of perioperative mortality after cardiothoracic surgery. Z Herz Thorax Gefäßchir 2001; 15:242–8.Search in Google Scholar
16 Stachon A, Eisenblätter K, Köller M, Holland-Letz T, Krieg M. Cytokines and erythropoietin in the blood of patients with erythroblastemia. Acta Haematol 2003; 110:204–6.10.1159/000074228Search in Google Scholar PubMed
17 Livingston DH, Anjarina D, Wu J, Hauser CJ, Chang V, Deitch EA, et al. Bone marrow failure following severe injury in humans. Ann Surg 2003; 238:748–53.10.1097/01.sla.0000094441.38807.09Search in Google Scholar PubMed PubMed Central
© Walter de Gruyter
